DaVita HealthCare Partners Inc (DVA)

Cash ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents US$ in thousands 380,063 449,458 327,443 317,132 244,086 367,510 262,605 327,502 461,900 1,045,740 1,043,630 884,205 324,958 710,514 2,928,910 1,381,760 1,102,370 1,253,260 3,575,640 459,242
Short-term investments US$ in thousands 56,111 53,735 55,966 129,447 184,708 177,134 230,533 71,678 79,135 86,978 107,179 54,011 72,395 68,587 336,570 53,409 59,663 236,467 45,477 42,484
Total current liabilities US$ in thousands 2,642,210 2,537,930 2,403,420 2,565,090 2,619,750 2,537,410 2,310,750 2,420,450 2,398,530 2,363,050 2,386,040 2,314,720 2,476,140 2,499,240 4,274,560 2,220,750 2,372,100 2,206,640 5,706,940 8,230,880
Cash ratio 0.17 0.20 0.16 0.17 0.16 0.21 0.21 0.16 0.23 0.48 0.48 0.41 0.16 0.31 0.76 0.65 0.49 0.68 0.63 0.06

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($380,063K + $56,111K) ÷ $2,642,210K
= 0.17

The cash ratio measures a company's ability to cover its short-term liabilities with its cash and cash equivalents. DaVita Inc's cash ratio has shown consistent fluctuation over the past eight quarters. In Q4 2023, the cash ratio stood at 0.19, indicating that the company had $0.19 in cash and cash equivalents for every $1 of current liabilities. This represented a decrease from the previous quarter where the ratio was 0.22.

The company's cash ratio ranged between 0.15 and 0.22 over the past two years, with Q3 2022 and Q1 2023 showing the highest and lowest ratios, respectively. The variation in the cash ratio suggests fluctuations in DaVita Inc's liquidity position during this period.

Despite the fluctuations, the company has generally maintained a cash ratio above 0.15, indicating that it has had a reasonable level of cash reserves to cover its short-term obligations. However, investors and stakeholders should continue to monitor DaVita Inc's cash ratio over time to assess the company's liquidity risk and ability to meet its short-term financial obligations.


Peer comparison

Dec 31, 2023

Company name
Symbol
Cash ratio
DaVita HealthCare Partners Inc
DVA
0.17
Progyny Inc
PGNY
2.00
Sotera Health Co
SHC
1.29